icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
Use of Ledipasvir/Sofosbuvir Fixed Dose Combination for Treatment of HCV Genotype-1 Infection in Patients Coinfected with HIV - Eradicate Study
 
 
  Reported by Jules Levin
AASLD 2014 Nov 9
 
Anu Osinusi1,2, Kerry Townsend1,2, Amy Nelson1,2, Anita Kohli3,4, Eric Meissner1, Chloe Gross3, Michael A. Polis1, Phil S Pang5, William T. Symonds5, Mohammed M. Sajadi1, John Hogan6, G. Mani Subramanian5, John G. McHutchison5, Henry Masur4, Shyam Kottilil1,2 for the NIAID/CC Hepatitis C ERADICATE team1,3,4 1Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Maryland, 2Dept of Infectious Diseases, University of Maryland, Baltimore, 3Leidos /SAIC-Frederick, Frederick National Laboratory for Cancer Research, Frederick, Maryland , 4Critical Care Medicine Department, NIH, Bethesda, Maryland , 5Gilead Sciences, Foster City, California, 6Unity Health Care Inc, Washington DC

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif